dpp-4 inhibitors and glp-1 agonists DPP4 vs | June 2021 | Clinical Corner How do SGLT-2 inhibitors, GLP-1
Description
doi: 10.1001/jama.2023.24945 32
This is still well within normal range and unlikely to affect performance or health
He also explores the potential link between MCAS and autism, shedding light on why this connection deserves more attention
Bethea M, Bozadjieva-Kramer N, Sandoval DA
We were doing studies, but we had a problem
Based on the available evidence, cagrilintide appears to have a more favorable body composition profile, though the magnitude of difference between the two compounds remains to be determined through direct comparison studies
